Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why ADMA Biologics Stock Is Soaring Today

TheMotleyFool

0 0

Why ADMA Biologics Stock Is Soaring TodayPhoto, wide shot, wide-angle lens, Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/80e18bfd-1ff8-4487-af62-1cdb7de1ceb6.png

Shares of ADMA Biologics (NASDAQ: ADMA) were soaring 17.2% higher as of 11:34 a.m. EST on Thursday. The big jump came after the biotech announced its preliminary 2019 Q4 results and provided a strategic outlook for 2020.

ADMA expects to report Q4 revenue of $11.9 million, nearly triple the revenue of $4.1 million posted in the prior-year period. For full-year 2019, the company's preliminary revenue totaled $29.2 million, up 72% year over year. ADMA also listed several strategic priorities for 2020, including expanding its commercial launches of Bivigam and Asceniv.

Image source: Getty Images.

Source Fool.com

Like: 0

ADMA

Teilen